Key result
Human adenovirus-36 seropositivity was associated with a lower odds of obesity in a Chinese Han population after adjusting for age and gender (OR 0.69; 95% CI 0.48-0.97; P=0.03).
Cross-Sectional (n=824)
HAdV-36 seropositivity may associate with obesity in Chinese adults; hypothesis-generating and requires prospective confirmation before clinical consideration.
The study aimed to explore the prevalence of human adenovirus-36 (HAdV-36) infection and the association of HAdV-36 with obesity in Chinese Han population. A qualitative determination using ELISA was performed to determine by duplication of the antibodies to HAdV-36 in the serum samples. Logistic regression analysis was used to analyze the association between HAdV-36 seropositivity and obesity. The overall HAdV-36 seroprevalence was 49.8% amongst 824 participants. The prevalence of HAdV-36 seropositive was 42.9 and 51.4% in the obese and non-obese participants, respectively, which was not statistically significant (P=0.05). There were significant differences in the anthropometric and biochemical parameters observed between the two groups except for height (P=0.067) and total cholesterol (TC) (P<0.29). After the adjustment for age and gender, HAdV-36 seropositivity was a protective factor for obesity (odds ratio (OR) = 0.69, 95% confidence intervals (95% CI) = 0.48–0.97, P=0.03). In the male population, the adjusted OR for AD-36 antibody-positive status was statistically decreased for obese adults (OR = 0.59; 95% CI = 0.39–0.91; P=0.02). However, the similar result was not obtained in the female population (OR = 0.90; 95% CI = 0.48–1.67; P=0.73). We found a high prevalence of HAdV-36 infection in China and significant association between HAdV-36 infection and obesity or weight gain after the adjustment for age and gender. The HAdV-36 infection may be related to the weight loss in Chinese Han population, especially in the male group, which needs to be further confirmed.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2018) conducted a cross-sectional in Obesity (n=824). Human adenovirus-36 (HAdV-36) seropositivity vs. HAdV-36 seronegativity was evaluated on Obesity (OR 0.69, 95% CI 0.48-0.97, p=0.03). Human adenovirus-36 seropositivity was associated with a lower odds of obesity in a Chinese Han population after adjusting for age and gender (OR 0.69; 95% CI 0.48-0.97; P=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: